Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
- Resource Type
- article
- Source
- Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
- Subject
Science - Language
- English
- ISSN
- 2041-1723